// App-Quantinova.ai

378 : Impact of concurrent medications use on outcome of pancreatic cancer: SEER Medicare analysis.

Researchers

Presenter

  • Muhammad Shaalan Beg

Principal Investigators

  • Tyler Stewart

  • Ang Gao

  • Chul Ahn

  • Jarett Berry

  • Eric Mortensen

Medical Centers

  • Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • The University of Texas Southwestern Medical Center, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Pancreatic cancer

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Thiazolidinedione

  • Metformin Hydrochloride

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved